A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells.
Authors: Serwotka-Suszczak AM, Sochaj-Gregorczyk AM, Pieczykolan J, Krowarsch D, Jelen F, Otlewski J.
Published in: International Journal of Molecular Sciences
Publication type: article
Subject areas: Biochemistry, Genetics and Molecular Biology; Chemical Engineering; Chemistry; Computer Science; Medicine
SJR best quartile: Q1